Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline

Objective: Therapy-related myeloid neoplasms (t-MN) account for approximately 10% to 20% of all cases of AML (acute myeloid leukemia), MDS (myelodysplastic syndrome) and MDS/MPN (myelodysplastic syndrome/myeloproliferative neoplasms), MDS, and MDS/MPN. In our study, we evaluated peripheral blood sme...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hasan Mutlu, Zeki Akca, Havva Uskudar Teke, Hediye Ugur
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Atatürk University 2011-12-01
Colecção:	Eurasian Journal of Medicine
Assuntos:	Anthracycline Breast cancer Chemotherapy side effect Leukemia Myelodysplasia
Acesso em linha:	http://www.eajm.org/text.php3?id=411
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!